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Résumé en
anglais
Mutations in the Optic Atrophy 1 gene (OPA1) were first identified in 2000 as the
main cause of Dominant Optic Atrophy, a disease specifically affecting the retinal
ganglion cells and the optic nerve. Since then, an increasing number of symptoms
involving the central, peripheral and autonomous nervous systems, with considerable
variations of age of onset and severity, have been reported in OPA1 patients. This
variety of phenotypes is attributed to differences in the effects of OPA1 mutations, to
the mode of inheritance, which may be mono- or bi-allelic, and eventually to somatic
mitochondrial DNA mutations. The diversity of the pathophysiological mechanisms
involved in OPA1-related disorders is linked to the crucial role played by OPA1 in the
maintenance of mitochondrial structure, genome and function. The neurological
expression of these disorders highlights the importance of mitochondrial dynamics in
neuronal processes such as dendritogenesis, axonal transport, and neuronal survival.
Thus, OPA1-related disorders may serve as a paradigm in the wider context of
neurodegenerative syndromes, particularly for the development of novel therapeutic
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